Payment overview · 2025
General Payments
$36.63
2 reported records · 2 companies
Healthcare provider profile · identity verified
Lisa Pham, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · SPRINGFIELD, MO · NPI 1275502379
Verified facts
What the public records show
CMS Open Payments records show Lisa Pham, M.D. received $36.63 in general payments during 2025 across 2 reported records.
Dexcom, Inc. accounted for 54.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $19.91 | 54.4% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $16.72 | 45.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $36.63 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $19.91 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $16.72 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 670 | 191 |
| Levothyroxine Sodium | Levothyroxine Sodium | 553 | 143 |
| Amlodipine Besylate | Amlodipine Besylate | 450 | 122 |
| Metoprolol Succinate | Metoprolol Succinate | 379 | 104 |
| Pantoprazole Sodium | Pantoprazole Sodium | 371 | 102 |
| Losartan Potassium | Losartan Potassium | 345 | 105 |
| Omeprazole | Omeprazole | 312 | 88 |
| Gabapentin | Gabapentin | 299 | 87 |
| Lisinopril | Lisinopril | 290 | 83 |
| Tramadol Hcl | Tramadol Hcl | 281 | 82 |
| Potassium Chloride | Potassium Chloride | 278 | 76 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 265 | 89 |
| Trazodone Hcl | Trazodone Hcl | 262 | 71 |
| Furosemide | Furosemide | 240 | 79 |
| Hydrochlorothiazide | Hydrochlorothiazide | 233 | 74 |
| Duloxetine Hcl | Duloxetine Hcl | 227 | 62 |
| Citalopram Hbr | Citalopram Hydrobromide | 220 | 52 |
| Eliquis | Apixaban | 207 | 40 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 198 | 58 |
| Metformin Hcl | Metformin Hcl | 197 | 58 |
| Alprazolam | Alprazolam | 184 | 54 |
| Tizanidine Hcl | Tizanidine Hcl | 179 | 56 |
| Tamsulosin Hcl | Tamsulosin Hcl | 177 | 45 |
| Pravastatin Sodium | Pravastatin Sodium | 172 | 49 |
| Simvastatin | Simvastatin | 163 | 45 |
| Allopurinol | Allopurinol | 142 | 43 |
| Sertraline Hcl | Sertraline Hcl | 140 | 39 |
| Irbesartan | Irbesartan | 139 | 34 |
| Bupropion Xl | Bupropion Hcl | 133 | 37 |
| Fluticasone Propionate | Fluticasone Propionate | 130 | 56 |
| Spironolactone | Spironolactone | 123 | 32 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 121 | 91 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 120 | 36 |
| Hydralazine Hcl | Hydralazine Hcl | 119 | 34 |
| Famotidine | Famotidine | 112 | 33 |
| Meloxicam | Meloxicam | 107 | 37 |
| Warfarin Sodium | Warfarin Sodium | 104 | 26 |
| Carvedilol | Carvedilol | 101 | 31 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 101 | 30 |
| Prednisone | Prednisone | 96 | 70 |
| Zolpidem Tartrate | Zolpidem Tartrate | 96 | 19 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 95 | 33 |
| Clopidogrel | Clopidogrel Bisulfate | 94 | 25 |
| Metoprolol Tartrate | Metoprolol Tartrate | 89 | 27 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 86 | 24 |
| Glimepiride | Glimepiride | 84 | 29 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 81 | 32 |
| Montelukast Sodium | Montelukast Sodium | 80 | 22 |
| Mirtazapine | Mirtazapine | 78 | 25 |
| Jardiance | Empagliflozin | 77 | 19 |
| Doxycycline Hyclate | Doxycycline Hyclate | 75 | 60 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 74 | 55 |
| Ezetimibe | Ezetimibe | 71 | 24 |
| Pregabalin | Pregabalin | 70 | 16 |
| Escitalopram Oxalate | Escitalopram Oxalate | 65 | 17 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 64 | 21 |
| Finasteride | Finasteride | 63 | 18 |
| Metformin Hcl Er | Metformin Hcl | 62 | 20 |
| Clonazepam | Clonazepam | 60 | 18 |
| Cefdinir | Cefdinir | 59 | 47 |
| Donepezil Hcl | Donepezil Hcl | 57 | 11 |
| Clonidine Hcl | Clonidine Hcl | 56 | 16 |
| Lorazepam | Lorazepam | 55 | 24 |
| Lansoprazole | Lansoprazole | 54 | 20 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 54 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 53 | 11 |
| Ondansetron Odt | Ondansetron | 51 | 14 |
| Ozempic | Semaglutide | 51 | 15 |
| Synthroid | Levothyroxine Sodium | 51 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 50 | 15 |
| Alendronate Sodium | Alendronate Sodium | 49 | 16 |
| Celecoxib | Celecoxib | 49 | 17 |
| Dicyclomine Hcl | Dicyclomine Hcl | 49 | 14 |
| Buspirone Hcl | Buspirone Hcl | 48 | 18 |
| Primidone | Primidone | 48 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 47 | 12 |
| Azelastine Hcl | Azelastine Hcl | 47 | 20 |
| Xarelto | Rivaroxaban | 47 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 45 | 11 |
| Topiramate | Topiramate | 44 | 11 |
| Dilt-Xr | Diltiazem Hcl | 40 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 39 | 14 |
| Repatha Sureclick | Evolocumab | 39 | suppressed |
| Atenolol | Atenolol | 38 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 37 | suppressed |
| Estradiol | Estradiol | 37 | 15 |
| Lidocaine | Lidocaine | 37 | suppressed |
| Mounjaro | Tirzepatide | 35 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 35 | 11 |
| Bumetanide | Bumetanide | 34 | suppressed |
| Temazepam | Temazepam | 34 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 34 | 21 |
| Fluconazole | Fluconazole | 33 | 18 |
| Symbicort | Budesonide/Formoterol Fumarate | 33 | 15 |
| Lovastatin | Lovastatin | 32 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 32 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 32 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 30 | 22 |
| Ramipril | Ramipril | 30 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 29 | suppressed |
| Baclofen | Baclofen | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 28 | 27 |
| Memantine Hcl | Memantine Hcl | 27 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 26 | suppressed |
| Entresto | Sacubitril/Valsartan | 26 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Myrbetriq | Mirabegron | 26 | suppressed |
| Nystatin | Nystatin | 26 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 26 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 26 | suppressed |
| Acyclovir | Acyclovir | 25 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 25 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 25 | suppressed |
| Methylprednisolone | Methylprednisolone | 25 | 22 |
| Solifenacin Succinate | Solifenacin Succinate | 25 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 25 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 24 | suppressed |
| Levofloxacin | Levofloxacin | 24 | 22 |
| Glipizide | Glipizide | 23 | suppressed |
| Azithromycin | Azithromycin | 22 | 16 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 22 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 21 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 21 | suppressed |
| Nifedipine Er | Nifedipine | 21 | suppressed |
| Verapamil Er | Verapamil Hcl | 21 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 20 | suppressed |
| Klor-Con M20 | Potassium Chloride | 20 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 20 | suppressed |
| Olanzapine | Olanzapine | 20 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 20 | suppressed |
| Chlorthalidone | Chlorthalidone | 19 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 19 | suppressed |
| Januvia | Sitagliptin Phosphate | 19 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 19 | suppressed |
| Ibuprofen | Ibuprofen | 18 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Levetiracetam | Levetiracetam | 17 | suppressed |
| Linzess | Linaclotide | 17 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 17 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | 12 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 16 | 16 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Victoza 3-Pak | Liraglutide | 16 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 15 | suppressed |
| Nexium | Esomeprazole Magnesium | 15 | suppressed |
| Nitroglycerin | Nitroglycerin | 15 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 14 | suppressed |
| Diazepam | Diazepam | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Mexiletine Hcl | Mexiletine Hcl | 14 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 14 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 13 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 13 | suppressed |
| Naproxen | Naproxen | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Lubiprostone | Lubiprostone | 12 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 12 | suppressed |
| Sulindac | Sulindac | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 11 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 11 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $36.63 · 2 records | Dexcom, Inc. | Dexcom G6 Transmitter, REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error